Co‐operation between viral oncogenes in avian erythroid and myeloid leukaemia

One of the most striking characteristics of tumours is their uncontrolled growth, suggesting that generation of neoplasms must be intimately linked with control of cell proliferation. During the last ten years, significant progress has been made towards an understanding of the mechanism of tumourigenesis, particularly through the discovery of genes that are involved in the generation of tumours, the so-called oncogenes. Oncogenes were first discovered in the genome of tumourinducing retroviruses known to efficiently cause various types of tumours in animals. These genes, referred to as ‘viral oncogenes’ or ‘u-onc’ genes are, however, not related to genes of non-oncogenic retroviruses, but have been captured from the cellular genome during evolution of these viruses. Oncogene capture can be easily explained through the life cycle of retroviruses, during which the viral genome is integrated into the DNA of the host cell, leading to potential capture and packaging of cellular genetic material into progeny virus by recombination. Certain human tumours (in general these are not caused by retroviruses) also contain oncogenes, which can be transferred to normal cells by transfixtion where they cause uncontrolled growth. Many of the human oncogenes turned out to be identical to oncogenes that had already been known from retroviruses (for reviews see [1,2,3,4]). Thus, one can assume that the mechanisms of tumourigenesis by viral and non-viral oncogenes are rather similar. The 40 to 50 oncogenes known to date are all derived from normal cellular genes, referred to as protooncogenes or ‘c-onc’ genes. Thus genes that can give rise to tumour-inducing oncogenes might constitute only a minute fraction of the c. 1OOOOO genes repre-

[1]  T. Graf,et al.  Relationships Between Oncogenes and Growth Control , 1990 .

[2]  H. Stunnenberg,et al.  Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product , 1989, Nature.

[3]  S. Ness,et al.  Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. , 1989, The EMBO journal.

[4]  A. Levitzki,et al.  Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors , 1988, Science.

[5]  A. Ullrich,et al.  Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. , 1988, The EMBO journal.

[6]  J. D. Engel,et al.  v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (Band 3) gene , 1988, Cell.

[7]  T. Graf,et al.  v-myb dominance over v-myc in doubly transformed chick myelomonocytic cells , 1987, Cell.

[8]  O. Gandrillon,et al.  The chicken c-erbA proto-oncogene is preferentially expressed in erythrocytic cells during late stages of differentiation , 1987, Molecular and cellular biology.

[9]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[10]  P. Vogt Onc genes and signals of cell growth. , 1987, Arzneimittel-Forschung.

[11]  J. Bishop The molecular genetics of cancer. , 1987, Science.

[12]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[13]  T. Graf,et al.  ts-oncogene-transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. , 1987, Haematology and blood transfusion.

[14]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[15]  H. Beug,et al.  The c-erb-A protein is a high-affinity receptor for thyroid hormone , 1986, Nature.

[16]  T. Graf,et al.  v-mil induces autocrine growth and enhanced tumorigenicity in v-myc-transformed avian macrophages , 1986, Cell.

[17]  T. Graf,et al.  v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation , 1986, Cell.

[18]  H. Land Oncogenes Cooperate, but How? , 1986 .

[19]  M. Schwab Amplification of Proto-Oncogenes and Tumor Progression , 1986 .

[20]  A. Balmain Molecular Events Associated with Tumor Initiation, Promotion, and Progression in Mouse Skin , 1986 .

[21]  R. Weinberg,et al.  Development of monoclonal antibodies reactive with the product of the neu oncogene. , 1986, Symposium on Fundamental Cancer Research.

[22]  C. Heldin,et al.  Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus , 1985, Nature.

[23]  Robert A. Weinberg,et al.  Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies , 1985, Cell.

[24]  T. Graf,et al.  Protein synthesis in differentiating normal and leukemic erythroid cells , 1985, Journal of cellular physiology.

[25]  A. Knudson Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[26]  A. Ullrich,et al.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbb protein , 1985, Cell.

[27]  T. Graf,et al.  Characterization of hematopoietic cells transformed in vitro by AEV-H, a v-erbB-containing avian erythroblastosis virus. , 1985, Haematology and blood transfusion.

[28]  T. Graf,et al.  Purification and characterization of cMGF, a novel chicken myelomonocytic growth factor. , 1984, The EMBO journal.

[29]  T. Graf,et al.  Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts to differentiate at the nonpermissive temperature , 1984, Cell.

[30]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[31]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[32]  D. Mann,et al.  Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Bishop Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[34]  T. Graf,et al.  Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes , 1983, Cell.

[35]  T. Graf,et al.  Avian leukemia viruses. Oncogenes and genome structure. , 1982, Biochimica et biophysica acta.

[36]  J. Samarut,et al.  Target cells infected by avian erythroblastosis virus differentiate and become transformed , 1982, Cell.

[37]  H. Zentgraf,et al.  Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus , 1982, Cell.

[38]  T. Graf,et al.  Characterization of the hematopoietic target cells of defective avian leukemia viruses by velocity sedimentation and density gradient centrifugation analyses. , 1981, Haematology and blood transfusion.

[39]  T. Graf,et al.  Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation , 1979, Cell.

[40]  T. Graf,et al.  Avian leukemia viruses: interaction with their target cells in vivo and in vitro. , 1978, Biochimica et biophysica acta.